All areas of devices and implants saw third quarter sales growth. Spine and biologics sales increased 1 percent to $6 million, while extremity implant sales jumped the most with 24 percent to $15.1 million.
Exactech’s year-to-date net income was reported at $10.8 million, up from $8.9 million last year.
More Articles on Devices:
Device Companies — 7 Key Notes — Medtronic, Wright Medical Group & More
Medtronic Launches New Procedure for Lateral Lumbar Spine Access
Providence Medical Technology Announces Positive 2-Year Follow-Up in Facet Device Study
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
